Is Tramadol Less Constipating Than Other Opioids?

Tramadol causes less constipation than stronger opioids like morphine and oxycodone, but the gap is narrower than many people expect. When compared to codeine, another weak opioid, the difference may vanish entirely. A randomized trial found that 40 percent of healthy volunteers met the diagnostic criteria for constipation after taking tramadol, and the drug still slows colonic transit by several hours compared to placebo. So while tramadol has a genuine advantage over the heavy hitters, calling it “easy on the gut” overstates the case.

How Tramadol Stacks Up Against Morphine and Oxycodone

The clearest advantage tramadol has is against strong opioids. In a head-to-head trial of patients with severe cancer pain, those on tramadol experienced less constipation than those on morphine, and the difference was statistically meaningful by the fourth day of treatment.¹ A palliative care review put it in practical terms: high doses of tramadol are less constipating than even small doses of morphine.²

The comparison with oxycodone follows a similar pattern. After knee surgery, patients given tramadol alone averaged about three days of constipation, while those on oxycodone averaged closer to five days. Nausea was also substantially lower in the tramadol group.³ These differences are real and consistent enough that clinicians sometimes choose tramadol precisely because they anticipate fewer bowel complaints.

That said, the comparison only holds against strong opioids given at standard analgesic doses. Once you move to other weak opioids or to opioids delivered through the skin (like fentanyl or buprenorphine patches), tramadol’s advantage shrinks or disappears.

The Codeine Comparison Is Murkier Than You’d Think

Since tramadol and codeine occupy the same rung on the analgesic ladder, this is the comparison many people actually care about. And the data here are frustratingly mixed.

A large retrospective study from Northwest England found that patients prescribed tramadol for non-cancer pain had a roughly 20 percent lower risk of severe constipation compared to those on codeine.⁴ That sounds meaningful, but the confidence interval just barely touched the line of no difference, so the result is borderline.

Meanwhile, a large cohort study published in JAMA found no significant difference at all. Constipation rates were nearly identical: about seven events per thousand person-years with tramadol versus about six with codeine.⁵ If anything, the point estimate in that study leaned slightly toward tramadol being worse, though the difference wasn’t statistically reliable.

These two studies aren’t directly contradictory. One tracked severe constipation requiring medical attention, while the other counted any constipation event recorded in the medical record. The doses, patient populations, and follow-up periods differed. But the bottom line for someone choosing between tramadol and codeine is sobering: you shouldn’t pick tramadol over codeine expecting a major improvement in bowel function. The evidence doesn’t support that expectation.

Why Tramadol Still Slows the Gut

The reputation tramadol has for being gentler on the bowels comes from its unusual pharmacology. Unlike morphine or oxycodone, which act almost exclusively through opioid receptors, tramadol does two things at once. It binds to opioid receptors in the brain and spinal cord (producing pain relief), and it also blocks the reuptake of serotonin and norepinephrine, adding a second layer of analgesia that has nothing to do with the opioid system. Because only part of its painkilling effect comes from opioid receptor activation, the thinking goes, it should produce less of the classic opioid side effects.

That reasoning has some truth to it. Tramadol and its main active breakdown product, called M1, do activate the μ-opioid receptor directly, but they need much higher concentrations to do so than a potent opioid like morphine.⁶ In practical terms, tramadol is a relatively weak opioid agonist. Weaker binding at gut opioid receptors should mean less disruption to normal bowel movements.

The catch is that “weaker” doesn’t mean “absent.” Rodent studies have confirmed that tramadol’s constipating effect is driven specifically by peripheral μ-opioid receptors in the gut. When researchers used mice that had been genetically engineered to lack those receptors, tramadol did not slow intestinal transit at all. In normal mice, it did. And in rats, the slowing was dose-dependent: more tramadol, more constipation.⁷ This tells us that tramadol causes constipation through the same fundamental mechanism as every other opioid. It just does so with less firepower.

What Happens to Gut Transit in Humans

If you zoom in on what tramadol actually does to the human digestive tract, two controlled studies paint a detailed picture, and they don’t entirely agree with each other.

An older study from the late 1990s gave healthy volunteers 50 mg of tramadol every six hours for several days and measured how quickly food moved through the gut. The median time for material to travel from mouth to the start of the large intestine was identical to placebo: 90 minutes in both groups. Total colonic transit time did increase somewhat with tramadol, from about 46 hours to about 59 hours, but that difference was not statistically significant, and 59 hours still fell within the normal range.⁸ The researchers concluded that tramadol has minimal effect on gut motor function, and this finding helped cement tramadol’s reputation as the “gentle” opioid.

A more recent randomized trial from 2024 challenged that conclusion. In this study, healthy volunteers given tramadol for five days showed a significant increase in colonic transit time: about 34 hours on tramadol versus 25 hours on placebo. The number of daily bowel movements dropped, stool consistency became firmer, and symptom scores for constipation jumped dramatically. By the end of the treatment period, 40 percent of the tramadol group met the formal diagnostic criteria for constipation. Nobody in the placebo group did.⁹

What explains the discrepancy? The doses and measurement methods differed. The newer study used a higher total daily dose and more sensitive imaging. It also specifically set out to test gut effects rather than just track them as an afterthought. The researchers behind it argued that tramadol’s constipating potential has been underestimated for decades, and that bowel symptoms should be proactively managed in anyone taking it for pain.

Constipation in Surgical Recovery

Postoperative settings offer a different lens on the question, because patients are often getting tramadol by injection alongside other opioids, and any delay in gut function can extend a hospital stay. After major bladder surgery, researchers found that the cumulative dose of tramadol patients received was an independent predictor of how long it took the gut to start working again. Higher tramadol doses meant longer times until patients could pass gas, tolerate a normal diet, and leave the hospital.¹⁰

This matters because some surgical teams assume tramadol will be “safe” for the gut in a way that other opioids aren’t. The dose-response relationship in that study suggests otherwise. In a postoperative patient whose bowel is already sluggish from anesthesia and handling during surgery, tramadol still adds measurable delay. It may add less delay than fentanyl at equivalent analgesic levels, but treating it as bowel-neutral is a mistake.

The Side-Effect Trade-Off With Tramadol

Constipation isn’t the only side effect people worry about, and tramadol’s overall profile is worth understanding in context. Across clinical trials in patients with chronic osteoarthritis pain, the most commonly reported problems with tramadol were nausea, dizziness, constipation, vomiting, sleepiness, and headache.¹¹ Constipation shows up on every list of tramadol side effects, consistently ranking among the top three or four, right alongside nausea.

What’s interesting about tramadol is that the nausea and dizziness tend to be more prominent than with some other opioids, precisely because of the serotonin and norepinephrine reuptake inhibition that gives it a constipation advantage. In other words, there’s a trade-off: you may get somewhat less constipation, but you may get more nausea, especially when starting the drug or increasing the dose. For some patients, especially those already prone to nausea, this trade-off makes tramadol worse overall even if the gut stays marginally more cooperative.

How Tramadol Compares to Tapentadol

Tapentadol is a newer analgesic that works through a similar dual mechanism: opioid receptor activation plus norepinephrine reuptake inhibition. People sometimes assume it has a similar constipation profile to tramadol. It doesn’t, and the reason highlights how specific pharmacological differences translate into real-world gut effects.

A narrative review comparing the two drugs found that tapentadol likely causes more constipation and more respiratory depression than tramadol, while causing less nausea and less serotonin-related toxicity.¹² The difference makes sense: tapentadol is a stronger opioid agonist than tramadol, so its greater opioid “load” produces more of the classic opioid side effects, including gut slowing. It lacks tramadol’s serotonin reuptake component, which is why serotonin-related problems like nausea are less of an issue.

For someone weighing options, this comparison reinforces the pattern. The constipation potential of any opioid tracks closely with how strongly it activates μ-opioid receptors in the gut. Tramadol activates them weakly; tapentadol activates them more strongly; morphine and oxycodone activate them strongly. The gut side effects follow that gradient fairly predictably.

Transdermal Opioids and the Delivery Route Factor

One dimension that often gets overlooked in the tramadol discussion is that how an opioid enters the body matters for constipation, not just which opioid it is. Opioids taken by mouth pass through the gut before reaching the bloodstream, giving them a direct opportunity to slow intestinal motility on the way through. Opioids delivered through the skin bypass the gut entirely on their first pass.

Transdermal fentanyl and buprenorphine patches have been observed to cause bowel dysfunction less frequently than oral opioids, even though constipation remains their most common side effect.² This complicates the straightforward ranking of tramadol as “less constipating.” Oral tramadol at moderate doses might cause more constipation than a low-dose fentanyl patch, even though fentanyl is a far more potent opioid. The delivery route reshuffles the hierarchy in a way that dose-equivalence tables don’t capture.

If constipation is your primary concern, the choice isn’t always between opioid A and opioid B. Sometimes it’s between oral delivery and transdermal delivery, or between a systemic opioid and a local or regional pain management strategy that avoids systemic opioids altogether.

Practical Steps If You’re Taking Tramadol

Given all of this, the evidence points to a few practical conclusions for anyone taking tramadol or considering it:

Expect some gut slowing: Even at standard doses, tramadol prolongs colonic transit and can produce constipation that meets formal diagnostic criteria. The 2024 randomized trial found that two in five healthy volunteers developed constipation during a five-day course.⁹
Don’t skip preventive measures: Just because tramadol is milder than morphine on the gut doesn’t mean you can ignore bowel management. Adequate fluid intake, dietary fiber, and over-the-counter laxatives are worth discussing with your prescriber from the start, not after constipation is already established.
Dose matters: The constipating effect is dose-dependent. If you’re on a higher dose of tramadol, your constipation risk climbs accordingly. This is the same pattern as every other opioid, and tramadol is not exempt from it.
The nausea trade-off is real: Some people tolerate tramadol’s gut effects well but find the nausea intolerable, especially during the first few days. If that happens, switching to a different opioid with less serotonergic activity might reduce nausea even if constipation ticks up slightly.

Individual Variation and Metabolism

One underappreciated wrinkle in all of this is that people metabolize tramadol at very different rates. Tramadol itself is a relatively weak opioid, but the liver converts it into M1, which is the metabolite that does most of the heavy lifting at the opioid receptor. The enzyme responsible for this conversion varies dramatically from person to person. Some people are ultrarapid metabolizers who produce a lot of M1 quickly, while others are poor metabolizers who barely convert tramadol at all.

This has direct implications for constipation. An ultrarapid metabolizer effectively gets a stronger opioid hit from the same tramadol dose, meaning more M1 reaching gut opioid receptors and more slowing of the bowel. A poor metabolizer gets less opioid effect overall, which may mean less constipation but also less pain relief. The same 50 mg pill can behave like a mild analgesic with minimal gut effects in one person and a moderately potent opioid with real constipation in another.

This metabolic variability also means that population-level studies can understate or overstate constipation risk for any given individual. If you find that tramadol constipates you severely at low doses, you may simply be someone who converts it efficiently. The drug isn’t failing to live up to its reputation; your body is just giving you more of the active metabolite than average.

When the Constipation Difference Actually Matters

For someone with mild-to-moderate pain who expects to take an opioid for a short period, say a few days after a dental procedure, the constipation difference between tramadol and a stronger opioid like oxycodone is meaningful. A few fewer days of constipation, as the knee surgery study showed, translates to a real quality-of-life benefit during recovery.³

For someone on long-term opioid therapy for chronic pain, the picture is less clear. Constipation becomes a cumulative, persistent problem regardless of which opioid you’re on. The modest advantage tramadol holds over morphine or oxycodone in week one can get swallowed by the reality that any ongoing opioid exposure keeps the gut in a chronically slowed state. At that point, the choice of opioid matters less than having a solid bowel management strategy in place and reassessing whether the opioid itself is still the right approach to pain.

Patients with pre-existing bowel conditions like irritable bowel syndrome with constipation, or people already taking other medications that slow the gut (certain antidepressants, antihistamines, iron supplements), face compounding effects. Tramadol’s “milder” constipation on top of an already sluggish baseline can still produce severe symptoms. For these patients, the margin tramadol buys over stronger opioids may not be enough to prevent the problem, and non-opioid pain strategies deserve early, serious consideration.